1. Field of Invention
The present invention relates to medical devices. More particularly, the invention relates to an implant which in one embodiment facilitates sutured side-to-side arteriovenous fistula (AVF) creation and maintains the patency thereof.
2. Background
End-stage renal disease (ESRD) is a growing problem in the United States and abroad, with the number of patients requiring treatment far outstripping the number of donor kidneys available. Those patients who are unable to receive a kidney transplant are treated by dialysis, with roughly ten times as many patients receiving hemodialysis as all other forms combined.
To minimize treatment time, hemodialysis requires a large blood volume flow rate. Increasing flow is typically achieved through the surgical creation of an arteriovenous shunt. This creates a low resistance pathway, significantly increasing flow through a graft or an arteriovenous fistula.
In practice, AVF is preferred to graft usage because fistulas have better long-term patency rates and reduced incidences of secondary interventions after creation. However, the surgical creation of an AVF and the subsequent venous tissue remodelling required to realize optimized flow rates is only successful in approximately half of surgical procedures. Failures involving AVF are largely due to stenosis via neointimal hyperplasia and thrombosis. A potential cause of neointimal hyperplasia is the exposure of venous tissue to the abnormal hemodynamic conditions resulting from significantly increased flow rates and pulsatility of the added arterial blood flow. In other cases, large flow rates can cause extreme dilation and result in oversized fistulas which fail to achieve the purpose for which they were created.
There exists a need for an improved method of creating arteriovenous fistula and maintaining the patency thereof, including implantation of devices designed to achieve these purposes.
The present invention provides a pair of device halves, each device half having a proximal end and a distal end, each of the device halves having an anastomosis window formed therethrough defining a first arch and a second arch opposite the first arch, the first and second arches being disposed normal to the proximal and distal ends, each device half having an inner surface and an outer surface opposite the inner surface, the device halves being connected at a proximal connector portion and at a distal connector portion on the inner surfaces defining a space therebetween and such that the anastomosis windows are in alignment with each other, the proximal connector portion and the distal connector portion defining a first suturing window and a second suturing window opposite the first suturing window, the first and second suturing windows being normal the anastomosis windows.
In another embodiment, the present invention provides a pair of device halves, each device half having a proximal end and a distal end, each of the device halves having an anastomosis window formed therethrough, the anastomosis window defining a first arch and a second arch opposite the first arch, the first and second arches being disposed normal to the proximal and distal end, each device half having an inner surface and an outer surface opposite the inner surface, the device halves being connected at a proximal connector portion and at a distal connector portion on the inner surfaces defining a space therebetween such that the anastomosis windows are in alignment with each other, the proximal connector portion and the distal connector portion defining a first suturing window and a second suturing window opposite the first suturing window, the first and second suturing windows being normal the anastomosis windows, each device half having a first flange proximally extending from the proximal end, each device half having a second flange distally extending from the distal end, the first flanges being spaced apart from each other defining a first flange gap, the second flanges being spaced apart from each other defining a second flange gap, each device half comprising a plurality of barbs attached to the first and second arches on the inner surface, each device half comprising a plurality of suture ports formed through the first flanges and the second flanges.
In another embodiment, the present invention provides a method of facilitating side-to-side fistula along a longitudinal portion of a vein and an artery, the vein having a vein wall, the artery having an artery wall. The method comprises in one step incising the vein wall substantially longitudinally to define a vein aperture, the vein wall comprising a first vein lip and a second vein lip opposite the vein aperture from the first vein lip. In a second step the method comprises incising the artery wall substantially longitudinally to define an artery aperture, the artery wall comprising a first artery lip and a second artery lip opposite the artery aperture from the first artery lip. The method includes implanting an anastomosis device in accordance with the principles of the present invention to form the side-to-side fistula. The implantation procedure includes disposing the second artery lip over one second arch and the second vein lip over the opposite second arch such that the second arches are disposed within the vein wall and the artery wall and such that the second vein lip and the second artery lip are disposed in the second suturing window; joining the second vein lip to the second artery lip by a first surgical method; disposing the first artery lip over one first arch and the first vein lip over the opposite first arch such that the first arches are disposed within the vein wall and the artery wall and such that the first vein lip and the first artery lip are disposed in the first suturing window; and joining the first vein lip to the first artery lip by a second surgical method.
Further objects, features, and advantages of the present invention will become apparent from consideration of the following description and the appended claims when taken in connection with the accompanying drawings.
The following provides a detailed description of currently preferred embodiments of the present invention. The description is not intended to limit the invention in any manner, but rather serves to enable those skilled in the art to make and use the invention.
In this description, when referring to a device, the term distal is used to refer to an end of a component which in use is furthest from the physician during the medical procedure, including within a patient. The term proximal is used to refer to an end of a component closest to the physician and in practice in or adjacent an external manipulation part of the deployment or treatment apparatus. Similarly, when referring to an implant such as an anastomosis device the term distal is used to refer to an end of the device which in use is furthest from the physician during the medical procedure and the term proximal is used to refer to an end of the device which is closest to the physician during the medical procedure.
The terms “substantially” or “about” used herein with reference to a quantity includes variations in the recited quantity that are equivalent to the quantity recited, such as an amount that is equivalent to the quantity recited for an intended purpose or function. “Substantially” or derivatives thereof will be understood to mean significantly or in large part.
In this disclosure, where directionality is addressed, a “top” element may also be a “first” element without being a top relative to another component, and a “bottom” element may also be a “second” element in likewise fashion.
The present disclosure generally provides an implant or device which facilitates the formation of an arteriovenous fistula and maintaining the patency thereof. Surgical fistula creation is presently the preferred method of increasing blood flow for end stage renal disease (ESRD) patients who are receiving hemodialysis. The advantages of fistulas over such treatments as grafts are numerous. For instance, of the treatment methods for ESRD patients that might be used to increase blood flow rates, arteriovenous fistulas (AVFs) are associated with decreased morbidity and mortality, and have the superior primary patency rates, the lowest rates of thrombosis, and require the fewest secondary interventions. AVFs generally provide longer hemodialysis access survival rates. Medical data shows that the total number of interventions during the life of the access is considerably lower for AVFs compared with AV grafts and that AVFs have lower rates of infection than AV grafts. The danger of infection is also decreased upon successful formation of an AVF. Thus, it is not surprising that AVFs also lead to lower hospitalization rates among ESRD patients who undergo some form of treatment to increase blood flow rates in order to facilitate hemodialysis.
However, there is a need to improve the ways that AVFs are created and maintained. Fewer than 15% of dialysis fistulas remain patent and can function without problems during the entire period of a patient's dependence on hemodialysis. The mean problem-free patency period after creation of native fistulas is approximately 3 years, whereas prosthetic polytetrafluoroethylene (PTFE) grafts last 1-2 years before indications of failure or thrombosis are noted. After multiple interventions to treat underlying stenosis and thrombosis, the long-term secondary patency rates for native fistulas are reportedly 7 years for fistulas in the forearm and 3-5 years for fistulas in the upper arm. Prosthetic grafts remain patent for up to 2 years.
For prosthetic grafts, fistula failure and eventual occlusion occur most commonly as a result of the progressive narrowing of the venous anastomosis; for native fistulas, failure occurs most commonly as a result of the narrowing of the outflow vein. The primary underlying pathophysiologic mechanism responsible for causing the failure is intimal hyperplasia at the anastomotic site. Additional causes include surgical and iatrogenic trauma, such as repeated venipunctures. Stenoses along the venous outflow and in intragraft locations (for prosthetic PTFE grafts) are also common.
The embodiments of the device described herein are designed in part to overcome these deficiencies. The anastomosis device provides a luminal region with a defined geometry for blood flow therethrough. It also provides a limited amount of contact between the intimal surfaces of the vessels to be connected by the fistula relative to methods of directly connecting the artery and the vein surgically.
Referring to
An alternative fistula arrangement, the side-to-side arteriovenous fistula, is illustrated in
The device is made of two device halves 60. In the embodiment illustrated in
The device halves 60 have an inner surface which provides a boundary for the device lumen 51 and also have a portion that does not face the device lumen 51. This latter portion is referred to as outer device surface 61. Outer device surface 61 is encompassed by portions of first arch 62 and second arch 63 and all other portions of device half 60 that are opposite to the device lumen 51. Outer device surface 61 curves away from the device lumen 51, giving each device a “C” shape when viewed head-on and giving the device 50 a butterfly shape when viewed in profile.
The embodiment of device 50 shown in
As mentioned previously, when there are no features of the device which impart a directionality or introduce an asymmetrical element to it, and the device is outside a surgical context (that is, it is not being used at that moment in a procedure or has not been implanted into a patient), the terms proximal and distal can be switched with one another. The terms top and bottom can be switched in a similar fashion. However, the outer portion of the device, including outer device surfaces 61, will remain an outer or exterior portion, and the device lumen 51 will remain interior, regardless of the designation of top/bottom and proximal/distal.
An anastomosis device 50 with the structural features described herein can be made of a number of different materials. Such a device 50 can be made of a biocompatible and biologically-inert material which will be well-tolerated by the tissues it contacts but will not encourage, for instance, growth of new intimal tissue across its openings. The device 50 can be made of a variety of polymers, including photosensitive polymers which are used for rapid prototyping applications. The polymers can have a stiffness ranging from relatively labile to relatively stiff, taking into account that the integrity of the anastomosis windows 58 must be maintained for optimal operation of the device. The device 50 may also be coated or impregnated with drugs which will prevent or slow endothelialization of the anastomosis windows 58 and thereby reduce the space available for blood flow through the AVF. The device may be made by a number of processes, including injection molding.
The slits to be cut into the artery walls and vein walls to provide openings for blood flow, when used in a device in accordance with an embodiment of the present invention will be made parallel to the direction of blood flow or substantially longitudinally. Put another way, the slitting is done parallel to a portion of a longitudinal axis of the vessel to be slit. Thus a longitudinal portion of a vein or of an artery comprises a portion which is parallel to the direction of blood flow, and can be in a plane substantially normal to the longitudinal axis. In many cases such a longitudinal portion may be about one centimeter in length. Therefore, a device 50 will have an anastomosis window 58 which extends for slightly greater than one centimeter in the proximal-to-distal dimension. It is possible that a favorable increase in blood flow through an AVF can be achieved with a fistula which is less than one centimeter wide, in which case it will be acceptable to construct a device 50 with an anastomosis window 58 which is less than 1 centimeter wide as well. Contrarily, certain patients may require that an AVF longer than one centimeter wide be constructed. In such cases, a device which has a longer anastomosis window 58 than one centimeter will be best suited for facilitating hemodialysis in such patients. The overall diameter of the device, as measured from one anastomosis window to another, may be about five to ten millimeters across.
In one embodiment the anastomosis windows are opposite and in alignment with one another across the body of the device such that blood may freely flow through the device. The first and second arches can be disposed normal to the proximal and distal ends of the device such that the planes of the proximal end or the distal end are substantially perpendicular to a plane that can be drawn through at least a portion of the arches. The first suturing window may be opposite the second suturing window and these may be disposed substantially normal the anastomosis windows. Thus there may be four planar faces of the device situated approximately 90 degrees from one another, each containing an anastomosis or a suturing window.
Referring now to
Between the first arches 62 and bounded by the proximal connecting portion 68 and the distal connecting portion 69 is a space which is the first suturing window 57. The second arches 63, the proximal connecting portion 68, and the distal connecting portion 69 frame a second suturing window. The first suturing window 57 and the second suturing window provide a top and bottom access, respectively, to the device lumen 51. The suturing windows are the spaces in which the vessels being manipulated to create the AVF will be sutured or otherwise connected together to form the top and bottom portions of the fistula.
In another embodiment of the device 50 in accordance with the principles of the present invention, the device of
Another embodiment has a plurality of bottom or second barbs 73 which assist in the gripping and stabilization of portions of vessel walls which have been pulled through the device lumen 51 and into the second suturing window. Analogously to top or first barbs 72, bottom or second barbs 73 are formed along a portion of second arch 63 and extend with their points within device lumen 51. The points are capable of securing the vascular material but are not sharp enough to pierce and damage it. A device may possess only top barbs 72, only bottom barbs 73, both top barbs 72 and bottom barbs 73, or no barbs at all.
The embodiment of device 50 illustrated in
Referring now to
Referring now to
Referring to
As mentioned, further steps may be incorporated into the method in accordance with other embodiments of the present invention. For instance, in the case of a device having at least one suture port, the vein 80 or artery 90 or both can be secured to the device 50 by suturing through the vessel walls and the ports. The vessels will then be thus secured to the device 50 and spaced apart from one another. Additionally, if the device 50 contains a plurality of top barbs 72 or a plurality of bottom barbs 73, the respective vessel portions may be secured thereon at the appropriate steps of the procedure.
As a person skilled in the art will readily appreciate, the above description is meant as an illustration of the implementation of the principles of this invention. This description is not intended to limit the scope or application of this invention in that the invention is susceptible to modification variation and change, without departing from the spirit of this invention, as defined in the following claims.
This application claims the benefit of U.S. Provisional Patent Application No. 61/952,984, filed on Mar. 14, 2014, the entire contents of which is hereby incorporated by reference.
Number | Date | Country | |
---|---|---|---|
61952984 | Mar 2014 | US |